| Authors | Ilaria Tanasi, Ibrahima Ba, Nicolas Sirvent, Thorsten Braun, Wendy Cuccuini, Paola Ballerini, Nicolas Duployez, Aline Tanguy-Schmidt, Jérôme Tamburini, Sébastien Maury, Eric Doré, Chantal Himberlin, Cédric Duclos, Patrice Chevallier, Philippe Rousselot, Massimiliano Bonifacio, Hélène Cavé, André Baruchel, Hervé Dombret, Jean Soulier, Judith Landman-Parker, Nicolas Boissel, Emmanuelle Clappier |
| Journal | Blood
(Blood)
Vol. 134
Issue 16
Pg. 1351-1355
(10 17 2019)
ISSN: 1528-0020 [Electronic] United States |
| PMID | 31434701
(Publication Type: Clinical Trial, Letter, Research Support, Non-U.S. Gov't)
|
| Chemical References |
- Antineoplastic Agents
- Oncogene Proteins, Fusion
- Protein Kinase Inhibitors
- ABL1 protein, human
- Proto-Oncogene Proteins c-abl
|
| Topics |
- Adolescent
- Adult
- Aged
- Antineoplastic Agents
(therapeutic use)
- Child
- Child, Preschool
- Female
- Gene Rearrangement
- Humans
- Male
- Middle Aged
- Oncogene Proteins, Fusion
(genetics)
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
(drug therapy, genetics)
- Protein Kinase Inhibitors
(therapeutic use)
- Proto-Oncogene Proteins c-abl
(genetics)
- Young Adult
|
